Thyrocare Technologies Ltd. Investor Presentation

Search Inside the pdf :

Thyrocare Technologies Ltd.

14 Oct 2025

452.90

-0.95%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Attached is herewith Investors presentation on unaudited financial results for the quarter and half year ended September 30, 2025, Interim dividend and proposal for issuance of Bonus Shares.

pdf

Thyrocare Technologies Ltd.

23 Jul 2025, 04:00PM

452.90

-0.95%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Attached is herewith is the Investors Presentation on Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2025.

pdf

Thyrocare Technologies Ltd.

23 Apr 2025, 04:38PM

452.90

-0.95%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Attached herewith Investor Presentation on Audited Financial Results (Standalone and Consolidated) for the Quarter and year ended March 31, 2025.

pdf

Thyrocare Technologies Ltd.

23 Oct 2024, 04:33PM

452.90

-0.95%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investors presentation of Unaudited financial results for quarter and half year ended September 30, 2024.

pdf

Thyrocare Technologies Ltd.

23 Jul 2024, 04:13PM

452.90

-0.95%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation of unaudited financial statements for the quarter ended June 30, 2024

pdf

Thyrocare Technologies Ltd.

14 May 2024

452.90

-0.95%

Investor Presentation

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are enclosing herewith a copy of the Investor presentation to be made to the investors at the earning conference call for Analysts and Investors to be held on May 14, 2024 on the audited financial results of the Company for the quarter and year ended March 31, 2024.

pdf